New Product - Nasodine Sinus Rinse
Filed with ASX ·
6ix is reading this filing.
Firebrick Pharma Limited on 6ix
Earlier from Firebrick Pharma
- Nasodine Nasal Spray Approved in the Philippines
- Firebrick Secures $732k in Strategic Investments
- Firebrick announces USA Retail Launch Plan
- Firebrick receives $293,000 R&D Tax Incentive
- Appendix 4E and Annual Report 30 June 2026
Later from Firebrick Pharma
All Firebrick Pharma news releasesFollow Firebrick Pharma into a list and get an email when it puts out news.
Follow Firebrick Pharma